Brief: FDA Discontinues Manufacture Of Dymista, Nasal Spray, 137 Ug 50 Ug
04/09/2025 16:34
Sept 4 (Reuters) - FDA: FDA: DISCONTINUATION OF MANUFACTURE OF DYMISTA, NASAL SPRAY, 137 UG; 50 UG Further company coverage: VTRS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viatris
See all newsBrief: Viatris Receives U.S. FDA Approval For Ryzumvi® For The Treatment Of Presbyopia
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Deals of the day-Mergers and acquisitions
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal